Lupus Nephritis
📧 Sign up to get email alerts when something new happens for Lupus Nephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients [Phase 4]
A Phase 4 clinical trial evaluating tacrolimus with steroids for lupus nephritis in Korean patients has been terminated.
-
FDA approval · 2024-10-22FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original application for a generic mycophenolate mofetil product.
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
A completed clinical trial evaluating the safety and efficacy of tacrolimus for lupus nephritis in actual-use conditions.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a fourth-generation CAR-T cell therapy targeting BCMA and CD19 for refractory systemic lupus erythemat…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients [Phase 4]
Phase 4 clinical trial evaluating the renoprotective effects of SGLT2 inhibitors and their impact on bone health in lupus nephritis patients…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis [Phase 3]
A Phase 3 study evaluating secukinumab plus standard of care versus placebo in active lupus nephritis was terminated, with results posted.
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients
This entry reports an ongoing clinical trial investigating whether renal arterial resistive index can serve as a noninvasive biomarker of di…
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients
The document describes a clinical trial investigating the association between neuropathy and certain autoantibodies in systemic lupus erythe…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: A Study of Telitacicept in Lupus Nephritis [Phase 2]
Phase 2 study of Telitacicept for lupus nephritis is currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Renal Survival in Patients with Lupus Nephritis
Clinical trial update regarding a NOT_YET_RECRUITING study on renal survival in patients with lupus nephritis. The sponsor listed is Assiut …
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Open-label Extension Study of Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Lupus Nephritis [Phase 3]
Open-label extension study evaluating secukinumab for active lupus nephritis was terminated; results were posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: A Study of ANX009 in Adult Participants With Lupus Nephritis [Phase 1]
A Phase 1 study of ANX009 in adults with lupus nephritis has completed.
-
FDA label_change · 2024-08-13FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Biocon Pharma Inc.)
FDA approved a supplemental application for Mycophenolic acid filed by Biocon Pharma Inc., updating the labeling for the product.
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for mycophenolate mofetil from Lannett Company, authorizing a generic version under ANDA 214525.
-
FDA approval · 2024-08-09FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for Accord Healthcare's generic mycophenolate mofetil.
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Urinary G3BP as a Novel Biomarker in Lupus Nephritis
This clinical trial update investigates urinary G3BP as a novel biomarker for lupus nephritis and indicates the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis. [Phase 2]
Phase 2 study evaluating safety, pharmacokinetics and preliminary efficacy of CFZ533 in lupus nephritis has completed, with results posted o…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease [EARLY_Phase 1]
An early-phase clinical trial (Phase 1) is evaluating the safety and potential efficacy of PRG-2311 for refractory lupus nephritis and IgG4-…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease [EARLY_Phase 1]
Early-phase clinical trial evaluating safety and efficacy of PRG-1801 for lupus nephritis and IgG4-related disease is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus [Phase 4]
A Phase 4 clinical trial is evaluating whether adding tacrolimus to mycophenolate mofetil helps taper steroids in systemic lupus erythematos…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital
A pediatric study at Sohag University Hospital investigates clinical characteristics, risk factors, and outcomes of lupus nephritis in child…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis [EARLY_Phase 1]
An early Phase 1 clinical trial at Chinese PLA General Hospital to evaluate mesenchymal stem cell transfusion for refractory lupus nephritis…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: T Regulatory Cells IN LUPUS NEPHRITIS
A clinical trial is investigating T regulatory cells for lupus nephritis, currently not yet recruiting.
-
CLINICAL_TRIALS withdrawal · 2024-05-13Clinical Trial Update: BAFF Levels and Lupus Nephritis (LN)
The clinical trial investigating BAFF levels in lupus nephritis has been withdrawn.
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis [Phase 3]
This update outlines a Phase 3 study of QLG1074 in combination with background therapy for active lupus nephritis. The trial is currently re…